Rational design and improvement of the dimerization‐disrupting peptide selectivity between ROCK‐I and ROCK‐II kinase isoforms in cerebrovascular diseases-Reference-Cited by-同舟云学术

Rational design and improvement of the dimerization‐disrupting peptide selectivity between ROCK‐I and ROCK‐II kinase isoforms in cerebrovascular diseases

Published:2020-01-29 Issue:6 Volume:33 Page:
ISSN:0952-3499
Container-title:Journal of Molecular Recognition
language:en
Short-container-title:J Mol Recognit

Author:

Gu Zhengtian¹,Yan Tingting²,Yan Fuling¹^ORCID

Affiliation:

1. Department of Neurology, Affiliated Zhongda Hospital, School of MedicineSoutheast University Nanjing China

2. Department of PediatricsAffiliated Huai'an Hospital of Xuzhou Medical University Huai'an China

Funder

The AZH foundation

AZH foundation

Publisher

Wiley

Subject

Molecular Biology,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmr.2835

Reference41 articles.

1. ROCKs: multifunctional kinases in cell behaviour

2. Physiological role of ROCKs in the cardiovascular system

3. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases

4. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice

5. Characterization of RhoA-binding Kinase ROKα Implication of the Pleckstrin Homology Domain in ROKα Function Using Region-specific Antibodies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROCK inhibitor: Focus on recent updates;Chinese Chemical Letters;2023-12

2. Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components;Genes;2023-01-20

3. The role of Rho/ROCK in epileptic seizure-related neuronal damage;Metabolic Brain Disease;2022-02-04

4. Directed Molecular Engineering of Mig6 Peptide Selectivity between Proto-oncogene ErbB Family Receptor Tyrosine Kinases;Biotechnology and Bioprocess Engineering;2021-04

5. Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy;Journal of Molecular Recognition;2021-03-08